Robo3 Blocking Peptide for STJ502785 peptide (STJ504856)

SPECIFICATIONS
ImmunogenSynthetic peptide corresponding to unique amino acid sequence on human RIG1 protein.
STJ504856-250
🚚 Free UK Delivery on orders over £150
Processing The item has been added
Enquire For Bulk Order
✓ 1-Year Performance Guarantee | SDS & Datasheet Included | Expert Tech Support | Covered by St John's Laboratory Guarantee

General Information

Short DescriptionRobo3 Blocking Peptide for STJ502785 is synthetically produced from the sequence and is suitable for use in western blot applications.
ApplicationsImmunodepletion/Immunocompetition
NoteSTRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.

Product Properties

FormulationLiquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice.
Storage InstructionStore at-20°C for long term storage. Avoid freeze-thaw cycles.

Target Information

Gene SymbolHomer1
Gene ID29546
Uniprot IDHOME1_RAT
ImmunogenSynthetic peptide corresponding to unique amino acid sequence on human RIG1 protein.
SpecificityThis blocking peptide is recommended for use in combination with Robo3 antibody, STJ502785

Additional Info

Tissue Specificity Highly expressed in cortex, Purkinje cells of the cerebellum, hippocampus, striatum and olfactory bulb. Isoform 1 and isoform 3 are expressed in skeletal and cardiac muscle.
Function Postsynaptic density scaffolding protein. Binds and cross-links cytoplasmic regions of GRM1, GRM5, ITPR1, DNM3, RYR1, RYR2, SHANK1 and SHANK3. By physically linking GRM1 and GRM5 with ER-associated ITPR1 receptors, it aids the coupling of surface receptors to intracellular calcium release. May also couple GRM1 to PI3 kinase through its interaction with AGAP2. Differentially regulates the functions of the calcium activated channel ryanodine receptors RYR1 and RYR2. Isoform 1 decreases the activity of RYR2, and increases the activity of RYR1, whereas isoform 3 counteracts the effects by competing for binding sites. Isoform 1 regulates the trafficking and surface expression of GRM5. Isoform 3 acts as a natural dominant negative, in dynamic competition with constitutively expressed isoform 1, and isoform 2 to regulate synaptic metabotropic glutamate function. Isoform 3, may be involved in the structural changes that occur at synapses during long-lasting neuronal plasticity and development. Forms a high-order complex with SHANK1, which in turn is necessary for the structural and functional integrity of dendritic spines. Negatively regulates T cell activation by inhibiting the calcineurin-NFAT pathway. Acts by competing with calcineurin/PPP3CA for NFAT protein binding, hence preventing NFAT activation by PPP3CA.
Peptide Name Homer Protein Homolog 1
Psd-Zip45
Vasp/Ena-Related Gene Up-Regulated During Seizure And Ltp 1
Vesl-1
Database Links Reactome: R-RNO-6794361
Cellular Localisation Cytoplasm
Postsynaptic Density
Synapse
Cell Projection
Dendritic Spine
Isoform 1 Inhibits Surface Expression Of Grm5 Causing It To Be Retained In The Endoplasmic Reticulum
Alternative Peptide Names Homer Protein Homolog 1 protein
Psd-Zip45 protein
Vasp/Ena-Related Gene Up-Regulated During Seizure And Ltp 1 protein
Vesl-1 protein
Homer1 protein
Homer protein
Vesl protein

Information sourced from Uniprot.org

Citations

Product Review

Well-cited Academic Publications
KO-Validated 700+ Lines
Technical Support Expert Scientific Team
1-Year Guarantee Antibodies & Proteins